Johannes Stegbauer1, Thomas M Coffman. 1. Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.
Abstract
PURPOSE OF REVIEW: The renin-angiotensin system (RAS) is critical for cardiovascular control, impacting normal physiology and disease pathogenesis. Although several biologically active peptides are generated by this system, its major actions are mediated by angiotensin II acting through its type 1 (AT1) and type 2 (AT2) receptors. Along with their effects to influence blood pressure and hemodynamics, recent studies have provided evidence that angiotensin receptors influence a range of processes independent from hemodynamic effects. RECENT FINDINGS: This review is focused on new molecular mechanisms underlying actions of AT1 receptors to influence vasoconstriction, inflammation, immune responses, and longevity. Moreover, we also highlight new advances in understanding functions of the AT2 receptor in end-organ damage, emphasizing the AT2 receptor as a potential therapeutic target in cardiovascular diseases. SUMMARY: Here we review recent advances in understanding the role of angiotensin receptors in normal physiology and disease states, focusing on their properties that may contribute to blood pressure regulation, end-organ damage, autoimmune disease and longevity.
PURPOSE OF REVIEW: The renin-angiotensin system (RAS) is critical for cardiovascular control, impacting normal physiology and disease pathogenesis. Although several biologically active peptides are generated by this system, its major actions are mediated by angiotensin II acting through its type 1 (AT1) and type 2 (AT2) receptors. Along with their effects to influence blood pressure and hemodynamics, recent studies have provided evidence that angiotensin receptors influence a range of processes independent from hemodynamic effects. RECENT FINDINGS: This review is focused on new molecular mechanisms underlying actions of AT1 receptors to influence vasoconstriction, inflammation, immune responses, and longevity. Moreover, we also highlight new advances in understanding functions of the AT2 receptor in end-organ damage, emphasizing the AT2 receptor as a potential therapeutic target in cardiovascular diseases. SUMMARY: Here we review recent advances in understanding the role of angiotensin receptors in normal physiology and disease states, focusing on their properties that may contribute to blood pressure regulation, end-organ damage, autoimmune disease and longevity.
Authors: Dominik N Muller; Erdenechimeg Shagdarsuren; Joon-Keun Park; Ralf Dechend; Eero Mervaala; Franziska Hampich; Anette Fiebeler; Xinsheng Ju; Piet Finckenberg; Jürgen Theuer; Christiane Viedt; Joerg Kreuzer; Harald Heidecke; Hermann Haller; Martin Zenke; Friedrich C Luft Journal: Am J Pathol Date: 2002-11 Impact factor: 4.307
Authors: Els Moltzer; Anna V A Verkuil; Richard van Veghel; A H Jan Danser; Joep H M van Esch Journal: Hypertension Date: 2009-12-21 Impact factor: 10.190
Authors: Wenjuan He; Yingying Wang; Ming-Zhi Zhang; Li You; Linda S Davis; Hong Fan; Hai-Chun Yang; Agnes B Fogo; Roy Zent; Raymond C Harris; Matthew D Breyer; Chuan-Ming Hao Journal: J Clin Invest Date: 2010-03-24 Impact factor: 14.808
Authors: Steven D Crowley; Matthew P Vasievich; Phillip Ruiz; Samantha K Gould; Kelly K Parsons; A Kathy Pazmino; Carie Facemire; Benny J Chen; Hyung-Suk Kim; Trinh T Tran; David S Pisetsky; Laura Barisoni; Minolfa C Prieto-Carrasquero; Marie Jeansson; Mary H Foster; Thomas M Coffman Journal: J Clin Invest Date: 2009-03-16 Impact factor: 14.808
Authors: Johannes Stegbauer; De-Hyung Lee; Silvia Seubert; Gisa Ellrichmann; Arndt Manzel; Heda Kvakan; Dominik N Muller; Stefanie Gaupp; Lars Christian Rump; Ralf Gold; Ralf A Linker Journal: Proc Natl Acad Sci U S A Date: 2009-08-19 Impact factor: 11.205
Authors: Michael Platten; Sawsan Youssef; Eun Mi Hur; Peggy P Ho; May H Han; Tobias V Lanz; Lori K Phillips; Matthew J Goldstein; Roopa Bhat; Cedric S Raine; Raymond A Sobel; Lawrence Steinman Journal: Proc Natl Acad Sci U S A Date: 2009-08-19 Impact factor: 11.205
Authors: Hongying Yang; Tianle Yang; Joseph A Baur; Evelyn Perez; Takashi Matsui; Juan J Carmona; Dudley W Lamming; Nadja C Souza-Pinto; Vilhelm A Bohr; Anthony Rosenzweig; Rafael de Cabo; Anthony A Sauve; David A Sinclair Journal: Cell Date: 2007-09-21 Impact factor: 41.582
Authors: Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas Journal: Pharmacol Rev Date: 2015-10 Impact factor: 25.468
Authors: Surawee Chuaiphichai; Victoria S Rashbrook; Ashley B Hale; Lucy Trelfa; Jyoti Patel; Eileen McNeill; Craig A Lygate; Keith M Channon; Gillian Douglas Journal: Hypertension Date: 2018-05-29 Impact factor: 10.190
Authors: Sergiy Sukhanov; Laura Semprun-Prieto; Tadashi Yoshida; A Michael Tabony; Yusuke Higashi; Sarah Galvez; Patrice Delafontaine Journal: Am J Med Sci Date: 2011-08 Impact factor: 2.378
Authors: Jianli Bi; Stephen A Contag; Luke C Carey; Lijun Tang; Nancy K Valego; Mark C Chappell; James C Rose Journal: J Renin Angiotensin Aldosterone Syst Date: 2012-11-16 Impact factor: 1.636
Authors: Danielle da C Silva; Vinicius G Maltarollo; Emmanuela Ferreira de Lima; Karen Cacilda Weber; Kathia M Honorio Journal: J Mol Model Date: 2014-06-17 Impact factor: 1.810